MEDTIDE (03880) has announced the successful conversion of 68.2011 million non-tradable shares into H shares, which was finalized on March 9, 2026. The converted H shares are scheduled to commence trading on the Stock Exchange of Hong Kong starting at 9:00 a.m. on March 10, 2026.